- Home
- MNKD vs PACS Comparison
MNKD vs PACS Comparison
Compare MNKD & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- PACS
- Stock Information
- Founded
- MNKD 1991
- PACS 2013
- Country
- MNKD United States
- PACS United States
- Employees
- MNKD N/A
- PACS N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- PACS
- Sector
- MNKD Health Care
- PACS
- Exchange
- MNKD Nasdaq
- PACS Nasdaq
- Market Cap
- MNKD 1.4B
- PACS 1.5B
- IPO Year
- MNKD 2004
- PACS 2024
- Fundamental
- Price
- MNKD $3.77
- PACS $13.21
- Analyst Decision
- MNKD Buy
- PACS Strong Buy
- Analyst Count
- MNKD 4
- PACS 7
- Target Price
- MNKD $9.75
- PACS $34.29
- AVG Volume (30 Days)
- MNKD 2.6M
- PACS 561.0K
- Earning Date
- MNKD 08-06-2025
- PACS 08-11-2025
- Dividend Yield
- MNKD N/A
- PACS N/A
- EPS Growth
- MNKD 228.27
- PACS 82.80
- EPS
- MNKD 0.10
- PACS 0.68
- Revenue
- MNKD $297,595,000.00
- PACS $3,558,953,000.00
- Revenue This Year
- MNKD $13.72
- PACS $29.74
- Revenue Next Year
- MNKD $15.21
- PACS $14.22
- P/E Ratio
- MNKD $36.35
- PACS $19.36
- Revenue Growth
- MNKD 32.50
- PACS 205.08
- 52 Week Low
- MNKD $3.63
- PACS $8.28
- 52 Week High
- MNKD $7.63
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- MNKD 34.62
- PACS N/A
- Support Level
- MNKD $3.63
- PACS N/A
- Resistance Level
- MNKD $3.85
- PACS N/A
- Average True Range (ATR)
- MNKD 0.15
- PACS 0.00
- MACD
- MNKD -0.02
- PACS 0.00
- Stochastic Oscillator
- MNKD 16.47
- PACS 0.00
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.